NO20004822D0 - Peroral virkestoffsuspensjon - Google Patents

Peroral virkestoffsuspensjon

Info

Publication number
NO20004822D0
NO20004822D0 NO20004822A NO20004822A NO20004822D0 NO 20004822 D0 NO20004822 D0 NO 20004822D0 NO 20004822 A NO20004822 A NO 20004822A NO 20004822 A NO20004822 A NO 20004822A NO 20004822 D0 NO20004822 D0 NO 20004822D0
Authority
NO
Norway
Prior art keywords
active substance
substance suspension
oral active
oral
suspension
Prior art date
Application number
NO20004822A
Other languages
English (en)
Other versions
NO20004822L (no
NO321401B1 (no
Inventor
Dietrich Tuerck
Veit Schmelmer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20004822D0 publication Critical patent/NO20004822D0/no
Publication of NO20004822L publication Critical patent/NO20004822L/no
Publication of NO321401B1 publication Critical patent/NO321401B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO20004822A 1998-03-27 2000-09-26 Farmasoytisk sammensetning for oral administrering og fremgangsmate for fremstilling derav NO321401B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (de) 1998-03-27 1998-03-27 Perorale Wirkstoff-Suspension
PCT/EP1999/001948 WO1999049845A1 (de) 1998-03-27 1999-03-23 Perorale wirkstoff-suspension

Publications (3)

Publication Number Publication Date
NO20004822D0 true NO20004822D0 (no) 2000-09-26
NO20004822L NO20004822L (no) 2000-11-23
NO321401B1 NO321401B1 (no) 2006-05-08

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004822A NO321401B1 (no) 1998-03-27 2000-09-26 Farmasoytisk sammensetning for oral administrering og fremgangsmate for fremstilling derav

Country Status (25)

Country Link
EP (2) EP0945131A1 (no)
JP (1) JP3323189B2 (no)
KR (1) KR100587208B1 (no)
CN (1) CN1150888C (no)
AR (1) AR016196A1 (no)
AT (1) ATE225648T1 (no)
AU (1) AU762464B2 (no)
BR (1) BR9909189A (no)
CA (1) CA2326048C (no)
CO (1) CO5070601A1 (no)
DE (1) DE59903023D1 (no)
DK (1) DK1066029T3 (no)
ES (1) ES2184428T3 (no)
HU (1) HU228474B1 (no)
IL (1) IL137479A (no)
MY (1) MY124599A (no)
NO (1) NO321401B1 (no)
NZ (1) NZ507610A (no)
PL (1) PL192969B1 (no)
PT (1) PT1066029E (no)
TR (1) TR200002772T2 (no)
TW (1) TWI232759B (no)
UY (1) UY25443A1 (no)
WO (1) WO1999049845A1 (no)
ZA (1) ZA200003951B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
WO2004089427A1 (en) * 2003-04-07 2004-10-21 Jurox Pty Ltd Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
WO2006061351A1 (en) * 2004-12-06 2006-06-15 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam
GB2438287A (en) 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
WO2011046853A1 (en) 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
JP6092629B2 (ja) * 2010-03-10 2017-03-08 ルピン・リミテッドLupin Limited リファキシミン使用準備済懸濁液
CN104016951B (zh) * 2010-03-19 2016-07-13 北京强新生物科技有限公司 靶向癌症干细胞的化合物和组合物
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
WO2014097685A1 (ja) * 2012-12-19 2014-06-26 三菱電機株式会社 空気調和機
BR112017023059B1 (pt) 2015-04-28 2022-07-05 Mars, Incorporated Processo para preparar um produto de ração úmida esterilizada, produto de ração úmida esterilizada, e seu uso
KR102145022B1 (ko) * 2018-08-14 2020-08-14 동아제약 주식회사 이부프로펜의 현탁액 조성물 및 투여 제형
CN112044605B (zh) * 2019-06-06 2022-06-21 钟志勇 选钛药剂及选钛方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (ja) * 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
UY25443A1 (es) 1999-11-17
ES2184428T3 (es) 2003-04-01
JP3323189B2 (ja) 2002-09-09
CN1150888C (zh) 2004-05-26
NO20004822L (no) 2000-11-23
TWI232759B (en) 2005-05-21
JP2002509875A (ja) 2002-04-02
CN1295462A (zh) 2001-05-16
AU762464B2 (en) 2003-06-26
IL137479A0 (en) 2001-07-24
TR200002772T2 (tr) 2000-12-21
EP0945131A1 (de) 1999-09-29
KR100587208B1 (ko) 2006-06-08
AR016196A1 (es) 2001-06-20
HU228474B1 (en) 2013-03-28
IL137479A (en) 2005-09-25
HUP0102036A3 (en) 2002-12-28
BR9909189A (pt) 2000-12-05
AU3147099A (en) 1999-10-18
EP1066029B1 (de) 2002-10-09
ATE225648T1 (de) 2002-10-15
DE59903023D1 (en) 2002-11-14
PL192969B1 (pl) 2006-12-29
DK1066029T3 (da) 2003-01-27
MY124599A (en) 2006-06-30
PL342345A1 (en) 2001-06-04
NZ507610A (en) 2003-08-29
NO321401B1 (no) 2006-05-08
KR20010042197A (ko) 2001-05-25
CA2326048C (en) 2008-08-12
HUP0102036A2 (hu) 2002-03-28
ZA200003951B (en) 2002-01-18
PT1066029E (pt) 2003-02-28
EP1066029A1 (de) 2001-01-10
CO5070601A1 (es) 2001-08-28
HK1034184A1 (en) 2001-10-19
CA2326048A1 (en) 1999-10-07
WO1999049845A1 (de) 1999-10-07

Similar Documents

Publication Publication Date Title
NO20004822L (no) Peroral virkestoffsuspensjon
FR2780269B1 (fr) Implant rachidien
DE69834425D1 (de) Unterstütztes implantat
DE69920227D1 (de) Fluoriertes elektret
ATE388677T1 (de) Zwischenwirbelimplantat
IS5568A (is) Lyfjafræðilega virkt morfólínól
DE59909242D1 (de) Referenzelektrode
EP1197204A4 (en) deodorants
DE60008009D1 (de) Einzelradaufhängung
DE60007530D1 (de) Oral wirksame androgene
DK1300129T3 (da) Implantathætteglas
DE59913860D1 (de) Mittelohrimplantat
DE69928344D1 (de) Pharmazeutisches Implantat
IS6134A (is) Ziprasídón sviflausn
DE69903524D1 (de) Pestizide hilfsmittel
DE69818638D1 (de) Zahnmedizinisches implantat
NO20002590D0 (no) Formuleringer omfattende oppløst paroxetin
FR2798583B1 (fr) Implant cotyloidien
ATA40797A (de) Implantat
NO20005769L (no) Cyklosporinderivater
FR2788685B1 (fr) Implant cothyloidien
DE69934741D1 (de) Aufhängevorrichtung
NO20005683D0 (no) Ny formulering inneholdende paroxetin
ATA65598A (de) Zahnimplantat
ID23006A (id) 13-dihidro-3' aziridino antrasiklina

Legal Events

Date Code Title Description
MK1K Patent expired